Dear Colleagues,

Understanding molecular mechanisms in neurodevelopment and neurodegenerative disorders is regarded as a key component to preventing the initiation of progressive mechanisms. Significant improvement in high throughput technologies such as epigenetics coupled with proteomics, bioinformatics, CRISPR/Cas9 screening, and high-throughput imaging are emerging tools to address molecular complexity of neurodevelopment and neurodegenerative disorders. In this issue, we aim to collect technical and conceptual advances as well as early investigations for emerging neurologic topics including but not limited to Synucleinopathies in Parkinson’s disease, tauopathies in Alzheimer’s disease, Gut-brain axis with inflammation, and microbiome associated epigenetic changes. Authors are invited to submit original research and review articles that seek to define epigenetic factors in neurodevelopment and neurodegenerative disorders.

Assis. Prof. Sung-Ung Kang

Guest Editor